REMINDER: Public Consultations of WP5 closing soon
You can still provide comments on the draft project plans for “Biodegradable stents for benign refractory esophageal stenosis” and “Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction” Biodegradable stents for benign refractory esophageal stenosis. Deadline for comments: 2 June, 2014. Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction. Deadline for comments: 6 June, […]
General Presentation on EUnetHTA
A General Presentation on EUnetHTA has been developed to present the history, development, activities as well as the relations with external collaboration partners of EUnetHTA. Find the presentation here.
[CLOSED] Public consultation of the Draft Project Plan on ‘Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction’
We are pleased to announce that as of today, 19 May, 2014, the Draft Project Plan on “Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction”, produced within WP5 Strand B, has entered the public consultation phase. This consultation will take place between 19 May and 6 June 2014. Objective of Draft Project Plan […]
[CLOSED] Public consultation of the Draft Project Plan on “Biodegradable stents for benign refractory esophageal stenosis”
We are pleased to announce that as of today, 12 May 2014, the Draft Project Plan on “Biodegradable stents for benign refractory esophageal stenosis” produced within WP5 Strand B, has entered the public consultation phase. This consultation will take place between 12 May and 2 June, 2014. Objective of Draft Project Plan The aim of […]
Upcoming public consultations
We are pleased to announce two upcoming public consultations produced within WP5 Strand B: 1) the Draft Project Plan on ‘Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction’ and 2) the Draft Project Plan on ‘Biodegradable stents for benign refractory esophageal stenosis’.<br> The consultation of the Draft Project Plan on ‘Biodegradable stents for […]
HTA 2.0 Europe – Teaming Up for Value: Registration is now OPEN!
Registration for the EUnetHTA Conference ”HTA 2.0 Europe – Teaming Up for Value” is now OPEN. Read more on the conference website: www.eunethta2014.it.
[CLOSED] Public Consultation of a Core Health Technology Assessment (Core HTA)
We are happy to announce that the first Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Fecal Immunochemical Test (FIT) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening” This consultation will take place between March 7 and April 11, 2014. Objective […]
New staff position at the EUnetHTA Secretariat
The EUnetHTA Secretariat (hosted by DHMA, Denmark) announces a new position of a scientific coordination officer to assist the scientific/technical cooperation activities in EUnetHTA Joint Action 2. The new staff member will be working at the Secretariat in Copenhagen in close cooperation with the rest of the Secretariat staff and the EUnetHTA JA2 partner organisations. […]
Second pilot rapid assessment on ‘canagliflozin for the treatment of type 2 diabetes mellitus’ available
We are pleased to announce the publication of the second pilot rapid assessment of WP5 Strand A. The pilot rapid assessment evaluates canagliflozin ‘Invokana’ and its use as a treatment of type 2 diabetes mellitus and is available here.
Did you mark your calendar for the EUnetHTA Conference “HTA 2.0 – Teaming up for Value”?
The Conference will take place October 30-31 2014, in Rome Italy. Information on venue and registration coming soon!
